Friedman G, Silva E, Vincent JL. Hat sich die Mortalität des septischen Schocks mit der Zeit verändert? Crit Care Med. 1998;26:2078-86.

Angus DC, Linde-Zwirble WT, Lidicker J. Epidemiology of severe sepsis in the United States: analysis of incidence, outcome, and associated costs of care. Crit Care Med. 2001;29:1303-10.

Martin GS, Mannino DM, Eaton S. The epidemiology of sepsis in the United States from 1979 through 2000. N Engl J Med. 2003;348:1546-54.

Linde-Zwirble WT, Angus DC. Severe sepsis epidemiology: sampling, selection, and society. Crit Care. 2004;8:222-6.

Dombrovskiy VY, Martin AA, Sunderram J. Rapid increase in hospitalization and mortality rates for severe sepsis in the United States: a trend analysis from 1993 to 2003. Crit Care Med. 2007;35:1244-50.

Rivers E, Nguyen B, Havstad S. Early goal-directed therapy in the treatment of severe sepsis and septic shock. N Engl J Med. 2001;345:1368-77.

Investigatoren ProCESS, Yealy DM, Kellum JA. A randomized trial of protocol-based care for early septic shock. N Engl J Med. 2014;370:1683-93.

Zielgerichtete Reanimation für Patienten mit frühem septischem Schock. N Engl J Med. 2014;371:1496-506.

Mouncey PR, Osborn TM, Power GS. Protocolised Management In Sepsis (ProMISe): a multicentre randomised controlled trial of the clinical effectiveness and cost-effectiveness of early, goal-directed, protocolised resuscitation for emerging septic shock. N Engl J Med. 2015;372:1301-11.

Phua J, Koh Y, Du B. Management of severe sepsis in patients admitted to Asian intensive care units: prospective cohort study. BMJ. 2011;342:d3245.

Beale R, Reinhart K, Brunkhorst FM. Promoting Global Research Excellence in Severe Sepsis (PROGRESS): lessons from an international sepsis registry. Infection. 2009;37:222-32.

. .

Marx G, Reinhart K. Venous oximetry. Curr Opin Crit Care. 2006;12:263-8.

ACCP/SCCM Consensus Conference: definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepse. Crit Care Med. 1992;20:864-74.

Richard C, Warszawski J, Anguel N. Early use of the pulmonary artery catheter and outcomes in patients with shock and acute respiratory distress syndrome: a randomized controlled trial. JAMA. 2003;290:2713-20.

Wheeler AP, Bernard GR, Thompson BT. Pulmonalarterien- versus zentraler Venenkatheter zur Steuerung der Behandlung der akuten Lungenverletzung. N Engl J Med. 2006;354:2213-24.

Harvey S, Harrison DA, Singer M. Assessment of the clinical effectiveness of pulmonary artery catheters in management of patients in intensive care (PAC-Man): a randomized controlled trial. Lancet. 2005;366:472-7.

Dellinger RP, Levy MM, Rhodes A. Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock: 2012. Crit Care Med. 2013;41:580-637.

Der Effekt einer frühen zielgerichteten Therapie auf die Behandlung von kritischen Patienten mit schwerer Sepsis/septischem Schock: eine multizentrische, prospektive, randomisierte, kontrollierte Studie. Zhongguo Wei Zhong Bing Ji Jiu Yi Xue. 2010;6:331-4.

Chawla LS, Zia H, Gutierrez G. Lack of equivalence between central and mixed venous oxygen saturation. Chest. 2004;126:1891-6.

Varpula M, Karlsson S, Ruokonen E. Mixed venous oxygen saturation cannot be estimated by central venous oxygen saturation in septic shock. Intensive Care Med. 2006;32:1336-43.

Van Beest PA, van Ingen J, Boerma EC. Keine Übereinstimmung von gemischtvenöser und zentralvenöser Sättigung bei Sepsis, unabhängig vom Sepsisursprung. Crit Care. 2010;14:R219.

Gattinoni L, Brazzi L, Pelosi P. A trial of goal-oriented hemodynamic therapy in critically ill patients. SvO2 Collaborative Group. N Engl J Med. 1995;333:1025-32.